This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Mast cell deficiency prevents BCR::ABL1 induced splenomegaly and cytokine elevation in a CML mouse model
Leukemia Open Access 09 May 2023
-
Gab2 deficiency prevents Flt3-ITD driven acute myeloid leukemia in vivo
Leukemia Open Access 13 December 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Pendergast AM, Quilliam LA, Cripe LD, Bassing CH, Dai Z, Li N et al. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell 1993; 75: 175–185.
Wohrle FU, Daly RJ, Brummer T . Function, regulation and pathological roles of the Gab/DOS docking proteins. Cell Commun Signal 2009; 7: 22.
Sattler M, Mohi MG, Pride YB, Quinnan LR, Malouf NA, Podar K et al. Critical role for Gab2 in transformation by BCR/ABL. Cancer Cell 2002; 1: 479–492.
Gu S, Chan WW, Mohi G, Rosenbaum J, Sayad A, Lu Z et al. Distinct GAB2 signaling pathways are essential for myeloid and lymphoid transformation and leukemogenesis by BCR-ABL1. Blood 2016; 127: 1803–1813.
Wohrle FU, Halbach S, Aumann K, Schwemmers S, Braun S, Auberger P et al. Gab2 signaling in chronic myeloid leukemia cells confers resistance to multiple Bcr-Abl inhibitors. Leukemia 2013; 27: 118–129.
Halbach S, Rigbolt KT, Wohrle FU, Diedrich B, Gretzmeier C, Brummer T et al. Alterations of Gab2 signalling complexes in imatinib and dasatinib treated chronic myeloid leukaemia cells. Cell Commun Signal 2013; 11: 30.
Halbach S, Hu Z, Gretzmeier C, Ellermann J, Wohrle FU, Dengjel J et al. Axitinib and sorafenib are potent in tyrosine kinase inhibitor resistant chronic myeloid leukemia cells. Cell Commun Signal 2016; 14: 6.
Aumann K, Lassmann S, Schopflin A, May AM, Wohrle FU, Zeiser R et al. The immunohistochemical staining pattern of Gab2 correlates with distinct stages of chronic myeloid leukemia. Hum Pathol 2011; 42: 719–726.
Koschmieder S, Gottgens B, Zhang P, Iwasaki-Arai J, Akashi K, Kutok JL et al. Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis. Blood 2005; 105: 324–334.
Koschmieder S, Schemionek M . Mouse models as tools to understand and study BCR-ABL1 diseases. Am J Blood Res 2011; 1: 65–75.
Schemionek M, Elling C, Steidl U, Baumer N, Hamilton A, Spieker T et al. BCR-ABL enhances differentiation of long-term repopulating hematopoietic stem cells. Blood 2010; 115: 3185–3195.
Nishida K, Wang L, Morii E, Park SJ, Narimatsu M, Itoh S et al. Requirement of Gab2 for mast cell development and KitL/c-Kit signaling. Blood 2002; 99: 1866–1869.
Holyoake TL, Jiang X, Jorgensen HG, Graham S, Alcorn MJ, Laird C et al. Primitive quiescent leukemic cells from patients with chronic myeloid leukemia spontaneously initiate factor-independent growth in vitro in association with up-regulation of expression of interleukin-3. Blood 2001; 97: 720–728.
Askmyr M, Agerstam H, Lilljebjorn H, Hansen N, Karlsson C, von Palffy S et al. Modeling chronic myeloid leukemia in immunodeficient mice reveals expansion of aberrant mast cells and accumulation of pre-B cells. Blood Cancer J 2014; 4: e269.
Kometani K, Aoki M, Kawamata S, Shinozuka Y, Era T, Taniwaki M et al. Role of SPA-1 in phenotypes of chronic myelogenous leukemia induced by BCR-ABL-expressing hematopoietic progenitors in a mouse model. Cancer Res 2006; 66: 9967–9976.
Bier D, Bartel M, Sies K, Halbach S, Higuchi Y, Haranosono Y et al. Small-molecule stabilization of the 14-3-3/Gab2 protein-protein interaction (PPI) interface. ChemMedChem 2015; 11: 911–918.
Acknowledgements
This study was supported in part by the Excellence Initiative of the German Research Foundation (GSC-4, Spemann Graduate School) and the José Carreras Leukämie Stiftung e.V. (project 13/12). RZ and TB are supported by the Deutsche Forschungsgemeinschaft via the Heisenberg-Program and the Centre for Biological Signalling Studies BIOSS (EXC 294).
Author contributions
All authors designed, analyzed and discussed experiments. SH, MK and FMU performed all mouse experiments. KA and JH conducted the histology analysis. SH wrote the manuscript together with SK, RZ, KA and TB. All authors reviewed and commented on the manuscript and accepted its final version.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Leukemia website
Supplementary information
Rights and permissions
About this article
Cite this article
Halbach, S., Köhler, M., Uhl, F. et al. Gab2 is essential for Bcr-Abl-mediated leukemic transformation and hydronephrosis in a chronic myeloid leukemia mouse model. Leukemia 30, 1942–1945 (2016). https://doi.org/10.1038/leu.2016.92
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2016.92
This article is cited by
-
Mast cell deficiency prevents BCR::ABL1 induced splenomegaly and cytokine elevation in a CML mouse model
Leukemia (2023)
-
Gab2 deficiency prevents Flt3-ITD driven acute myeloid leukemia in vivo
Leukemia (2022)
-
BRAF inhibition upregulates a variety of receptor tyrosine kinases and their downstream effector Gab2 in colorectal cancer cell lines
Oncogene (2018)
-
Protein-Dysregulationen in humanen und murinen myeloproliferativen Neoplasien
Der Pathologe (2018)